No abstract available.
Retreatment* ; Treatment Failure*

No abstract available.
Humans ; Ovarian Neoplasms ; Treatment Failure

No abstract available.
Humans ; Prognosis ; Treatment Failure ; Uterine Cervical Neoplasms

Our study was performed to evaluate the efficacy of anthralin-UVB therapy for psoriasis by simplifying the conventional Ingram regimen, 34 patients(21 admitted, and 13 OPD patients) were included in our study and the resulti can be summarized as follows. 1. There were no cases of treatment failure. 16 patients(76. 2%) out of the 2l admitted patients and 7 patients(53.8%) out of the 13 OPD patients showed clearing. 2. In the case of the admitted patients, the mean numbers of therapy(days) of the improved patients reaching grade 4 were 12. 0(18. 1 days) in the trunk lesions and 15. 5 (22. 0 days) in the extremity lesions' and those of the cleared patients reaching grade 4 were 11. 2(16. 0 days) in the trunk lesions, and 13. 4(lg. 5 days) in the extremity lesions, but the difference was not significant statistically(pp o.ps). The difference between the therapeutic effects of the admitted and the OPD patients was significant statistically(p<0. 05). 3. There were some notable side effects such as staining, pruritus, and erythema, but there were no cases of therapy termination.
Erythema ; Extremities ; Humans ; Pruritus ; Psoriasis* ; Treatment Failure

Retinoblastoma is the most common ocular malignancy in childhood. The association of bilateral retinoblastoma with ectopic midline intracranial tumor, trilateral retinoblastoma syndrome, is rare, but the prognosis is very poor with even with various combination treatments of surgery, chemotherapy, and radiotherapy including neuraxis. The cause of treatment failure was tumor dissemination along the neuraxis in approximately 50% of the cases. We experienced three cases of trilateral retinoblastoma, and two of them are alive so far with multi-modal treatment.
Drug Therapy ; Prognosis ; Radiotherapy ; Retinoblastoma* ; Treatment Failure

Myxomas are the most common type of primary cardiac tumour with 86% occurring in the left atrium. Right atrial myxomas is far less common. Patients usually present with progressive dyspnoea, fever, weight loss, right-sided heart failure, or pulmonary embolisation. We report the case of a 55-year-old man who presented with progressive dyspnoea and signs of right heart failure secondary to a large right atrial myxoma, which was diagnosed with a bedside transthoracic echocardiogram. This was successfully removed surgically.
Atrial Myxoma ; Dyspnea ; Heart Failure ; Treatment Outcome

BACKGROUND/AIMS: Ciprofloxacin has been widely prescribed for acute infectious diarrhea. However, the resistance to this drug is increasing. Rifaximin is a novel but poorly absorbed rifamycin derivative. This study evaluated and compared the efficacies of rifaximin and ciprofloxacin for the treatment of acute infectious diarrhea. METHODS: We performed a randomized controlled multicenter study in Korea. Patients with acute diarrhea were enrolled and randomized to receive rifaximin or ciprofloxacin for 3 days. The primary efficacy endpoint was the time to last unformed stool (TLUS). Secondary endpoints were enteric wellness (reduction of at least 50% in the number of unformed stools during 24-hour postenrollment intervals), general wellness (subjective feeling of improvement), and proportion of patients with treatment failure. RESULTS: Intent-to-treat analysis (n=143) showed no significant difference between the rifaximin and ciprofloxacin groups in the mean TLUS (36.1 hours vs 43.6 hours, p=0.163), enteric wellness (49% vs 57%, p=0.428), general wellness (67% vs 78%, p=0.189), or treatment failure rate (9% vs 12%, p=0.841). The adverse events did not differ significantly between the two groups. CONCLUSIONS: These results suggest that rifaximin is as safe and effective as ciprofloxacin in the treatment of acute infectious diarrhea.
Ciprofloxacin ; Diarrhea ; Humans ; Korea ; Rifamycins ; Treatment Failure

No abstract available.
Pneumothorax, Artificial* ; Treatment Failure* ; Tuberculosis, Pulmonary*

We had treated the 331 patients with lower ureter stone with EDAP-LT01 lithotriptor, Surveying 231 patients of them. whose retrospective study (or prospective) was possible, we have analyzed the factors that influenced on the treatment effect. So we got the following results. Most of stone size was ranged from 0.61 to 0.90 cm (38.6%). Stone clearance was achieved in 220 cases at 15 month and treatment failure was 11 cases (4.7%). Of the 220 patients, location of stone was more than 3.1 cm above ischial spine(IS) on KUB in 5 cases. Between 1.1-3.0 cm above it in 35 cases, +/-1. 0 cm of IS were 170 cases, and more than 1.1-3.0 cm below of it in 10 cases. There was no difference in the amount of total storage of shockwave in stone clearance according to location of stones, but high storage of shock wave required on cases of 3.1 cm above IS group. The 220 patients were grouped by in situ lower ureter stone at the time of the first visit to the hospital (158 cases), migration from upper stone (55 cases) and steinstrasse from upper tract stone (7 cases). The amount of shock wave consumption was 216.4, 301.2, 407.7 respectively, so initially lower ureter stone were treated with more effectiveness. Of the 220 cases, there were 184 cases of mild ureteral dilation, 34 cases of moderate ureteral dilation and 2 cases of severe ureteral dilation. The amount of shock wave consumption was 224, 295, 795 respectively. So treatment of these cases also showed significant difference (p=0.021). From these results, we concluded that effectiveness of ESWL against lower ureteral stone was related to the degree of ureteral dilatation, location of stone and situation of the stone migration within the ureter.
Dilatation ; Humans ; Retrospective Studies ; Shock ; Treatment Failure ; Ureter*

Transarterial chemoembolization (TACE) is the worldwide procedure performed for patients with various stage hepatoceullar carcinoma (HCC), but is not yet considered as curative treatment because of relatively high local recurrence rate. Moreover, many clinicians frequently experience treatment failure (incomplete necrosis or stage progression etc.) after repeated TACE, but no clear guidelines have been recommended about salvage treatment modalities for this situation. Recently, studies for combination of radiation therapy and TACE for HCC with TACE refractoriness have been tried and reported better therapeutic efficacy. Based on above suggestions, we herein offer our experience of a patient with macrovascular invasion developed after repeated TACE that achieve complete remission by stereotactic body radiation therapy. Further study, maybe regarding a combination of locoregional and systemic therapy, is necessary on how to manage HCC patients with TACE refractoriness.
Carcinoma, Hepatocellular* ; Humans ; Necrosis ; Recurrence ; Salvage Therapy ; Treatment Failure